Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4573404
Max Phase: Preclinical
Molecular Formula: C11H12ClN3O3S
Molecular Weight: 301.75
Molecule Type: Unknown
Associated Items:
ID: ALA4573404
Max Phase: Preclinical
Molecular Formula: C11H12ClN3O3S
Molecular Weight: 301.75
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)S(=O)(=O)c1cc(NC(=O)CC#N)ccc1Cl
Standard InChI: InChI=1S/C11H12ClN3O3S/c1-15(2)19(17,18)10-7-8(3-4-9(10)12)14-11(16)5-6-13/h3-4,7H,5H2,1-2H3,(H,14,16)
Standard InChI Key: LEXCPKGTZXTSMM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 301.75 | Molecular Weight (Monoisotopic): 301.0288 | AlogP: 1.44 | #Rotatable Bonds: 4 |
Polar Surface Area: 90.27 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.30 | CX Basic pKa: | CX LogP: 0.82 | CX LogD: 0.82 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.91 | Np Likeness Score: -2.72 |
1. Xie Y, Tummala P, Oakley AJ, Deora GS, Nakano Y, Rooke M, Cuellar ME, Strasser JM, Dahlin JL, Walters MA, Casarotto MG, Board PG, Baell JB.. (2020) Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 Inhibitors., 63 (6): [PMID:32105470] [10.1021/acs.jmedchem.9b01391] |
Source(1):